Amphenol vs Pfizer: Founders, CEOs and History
Amphenol was founded in 1932 by Arthur J. Schmitt and is led by R. Adam Norwitt. Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla.
Company facts
Founders
Amphenol
Arthur J. Schmitt
Amphenol was founded in Chicago in 1932 by an effective, pragmatic entrepreneur named Arthur J. Schmitt.
Pfizer
Charles Pfizer
Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.
Charles Erhart
Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…
CEOs and their tenures
Amphenol
- Arthur J. Schmitt1932–1964
Founder and Chief Executive Officer
Arthur J. Schmitt founded American Phenolic Corporation in Chicago in 1932 and led it as chief executive until 1964.
Source - Martin H. Loeffler1996–2008
Former Chief Executive Officer and Chairman
Martin H. Loeffler was Amphenol's chief executive from 1996 to 2008, president from 1987 to 2006 and chairman of the board from 1997 until he retired from the board at the May 2026 annual meeting.
Source - R. Adam Norwitt2009–present
Chairman, President and Chief Executive Officer
R. Adam Norwitt has been Amphenol's chief executive since January 1, 2009 and added the role of chairman of the board in 2026. Net sales grew from $2.82 billion in 2009 to $23.09 billion in fiscal 2025 and the GAAP operating margin reached a record 25.4%.
Source
Pfizer
- Ian Read2010–2018
Chief Executive Officer
He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.
Source - Albert Bourla2019–present
Chairman and Chief Executive Officer
A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
Source - Dave Denton2022–2026
Chief Financial Officer
As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.
Source - Chris Boshoff2025–present
Chief Scientific Officer and President, Research & Development
He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.
Source - Cecile Guegan2026–present
Interim Chief Financial Officer
She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.
Source
Timeline: Amphenol and Pfizer side by side
1849Pfizer
Pfizer Founded
Charles Pfizer and Charles Erhart founded the company in Brooklyn.
1932Amphenol
Arthur J. Schmitt founds American Phenolic Corporation
Arthur J. Schmitt incorporates American Phenolic Corporation in Chicago with a patented molded phenolic radio tube socket, establishing the company's foundation in electronic component manufacturing.
1936Amphenol
Introduction of industry-standard 75 series microphone connector and lock-in socket
Amphenol introduces the 75 series uniform microphone connector and a lock-in socket for radio tubes, both becoming industry standards and attracting RCA as a major customer ordering 10,000 sockets daily.
1942Amphenol
Primary supplier of AN connectors for WWII Allied forces
Amphenol becomes a critical defense supplier, with its 5015 AN circular connectors becoming standard equipment on military aircraft and communications gear; A-N connector shipments increase 13,572% from January 1941 to March 1943.
1942Amphenol
Official name change to Amphenol Electronics Corporation
The company officially changes its name from American Phenolic Corporation to Amphenol Electronics Corporation, formalizing the shorthand name customers had used for years.
1944Pfizer
Penicillin Scale-Up
Pfizer helped industrialize penicillin production during World War II.
1945Amphenol
Initial public offering
Amphenol raises $1.5 million from convertible debentures and sells 345,000 shares at $10 per share, giving the company a $4 million market capitalization and providing capital for post-war diversification.
1951Amphenol
Amphenol engineers develop the BNC connector
Amphenol engineers Paul Neill and Carl Concelman develop the bayonet coupled BNC coaxial connector, which becomes a standard interface in radio frequency and test equipment applications.
1957Amphenol
NYSE listing
Amphenol Electronics Corporation lists on the New York Stock Exchange, marking its transition to a major public industrial company.
1958Amphenol
Merger with George W. Borg Corporation
Amphenol completes its largest transaction to date, merging with the George W. Borg Corporation, a maker of automobile clocks, electronic instruments and deep pile fabrics, and is renamed Amphenol-Borg Electronics Corporation.
1967Amphenol
Acquisition by Bunker-Ramo Corporation
Bunker-Ramo Corporation acquires Amphenol, which begins operating as a subsidiary and passes through successive corporate owners for the next 24 years.
1981Amphenol
Allied Corporation buys Bunker-Ramo for $358 million
Allied Corporation acquires Bunker-Ramo for $358 million, including the Amphenol division, making Amphenol part of a larger industrial conglomerate.
1987Amphenol
LPL Investment leveraged buyout for $430 million
LPL Investment buys Amphenol from Allied in a leveraged buyout valued at $430 million in cash, and the decentralized management style that defines the modern company takes hold. Martin H. Loeffler becomes president in the same year.
1991Amphenol
Second IPO on NYSE under ticker APH
Amphenol returns to public markets with a second initial public offering on the New York Stock Exchange under ticker APH, beginning the modern era of sustained growth and shareholder returns.
1998Pfizer
Viagra Approved
The FDA approved Viagra in 1998.
2000Pfizer
Warner-Lambert Deal
Pfizer acquired Warner-Lambert, adding Lipitor.
2005Amphenol
Acquisition of Teradyne connector business for $390 million
Amphenol acquires Teradyne's connection systems business for $390 million in October 2005, expanding its presence in high speed data and backplane connectors for the growing IT datacom market.
2016Amphenol
Acquisition of FCI Asia for $1.275 billion
Amphenol acquires FCI Asia from affiliates of Bain Capital for $1.275 billion in January 2016, strengthening its global connector footprint and adding high speed backplane and board-to-board capability.
2019Pfizer
Albert Bourla becomes CEO
Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
2020Pfizer
BioNTech COVID Vaccine Partnership
Pfizer and BioNTech brought Comirnaty through emergency authorization.
2021Amphenol
Acquisition of MTS Systems Corporation for $1.7 billion
Amphenol acquires MTS Systems for $1.7 billion in April 2021, adding advanced sensor capability that deepens its position in industrial and automotive sensing.
2023Pfizer
Seagen Acquisition
Pfizer completed the $43 billion Seagen acquisition.
2024Amphenol
Acquisition of Carlisle Interconnect Technologies for about $2.0 billion
Amphenol completes the purchase of Carlisle Interconnect Technologies from Carlisle Companies in May 2024 for about $2.0 billion, expanding aerospace, defense and medical harsh environment interconnect capability.
2025Amphenol
Completion of the $2.1 billion CommScope outdoor wireless and DAS purchase
Amphenol completes the acquisition of CommScope's Outdoor Wireless Networks and Distributed Antenna Systems businesses, including Andrew, for $2.1 billion in cash. The businesses had about $1.2 billion of 2024 sales.
2025Amphenol
Record fiscal 2025 revenue of $23.09 billion, up 52%
Amphenol reports record full year 2025 net sales of $23.09 billion, up 52% year over year and 38% organically, with a 25.4% GAAP operating margin, $4.4 billion of free cash flow and Communications Solutions sales up 91% to about $12.1 billion.
2025Pfizer
Chris Boshoff Becomes CSO
Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
2025Pfizer
Metsera Acquisition
Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.
2025Pfizer
FY2025 Revenue Base
Pfizer reported $62.579 billion of FY2025 revenue.
2026Amphenol
Completion of the $10.5 billion CommScope CCS acquisition
Amphenol closes its largest acquisition, buying CommScope's Connectivity and Cable Solutions business for $10.5 billion on January 12, 2026. Amphenol also acquired the CommScope name and expects the business to generate about $4.1 billion of sales in 2026.
2026Amphenol
Norwitt named chairman as Loeffler retires from the board
Amphenol announces on February 4, 2026 that chief executive R. Adam Norwitt will also become chairman of the board at the May 2026 annual meeting, as Martin H. Loeffler retires from the board after more than five decades with the company.
2026Pfizer
Innovent Oncology Collaboration
Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.
Acquisitions
Amphenol
- CommScope Connectivity and Cable Solutions (CCS)2026$10.5B
- CommScope Outdoor Wireless Networks and Distributed Antenna Systems businesses (Andrew)2025$2.1B
- Rochester Sensors2025Undisclosed
- Trexon2025$1B
- Carlisle Interconnect Technologies (CIT)2024$2B
Pfizer
- Metsera, Inc.2025$7B
- Seagen Inc.2023$43B
- Medivation Inc.2016$14B
- Wyeth2009$68B
- Pharmacia Corporation2003$60B
- Warner-Lambert Company2000$111B
Questions about Amphenol vs Pfizer
Who is the CEO of Amphenol Corporation and Pfizer Inc.?
Amphenol Corporation is led by R. Adam Norwitt and Pfizer Inc. is led by Albert Bourla. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Amphenol Corporation founded vs Pfizer Inc.?
Pfizer Inc. was founded in 1849 — 83 years before Amphenol Corporation, which was founded in 1932. Pfizer Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Amphenol Corporation.
How many employees does Amphenol Corporation have compared to Pfizer Inc.?
Amphenol Corporation employs approximately 170,000 people, while Pfizer Inc. employs approximately 75,000. Amphenol Corporation has the larger workforce at 170,000 employees, compared to Pfizer Inc.'s 75,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Amphenol Corporation and Pfizer Inc. headquartered?
Both Amphenol Corporation and Pfizer Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Amphenol Corporation and Pfizer Inc.?
Amphenol Corporation was founded by Arthur J. Schmitt. Pfizer Inc. was founded by Charles Pfizer, Charles Erhart.
Which company has a longer operating history — Amphenol Corporation or Pfizer Inc.?
Pfizer Inc. has been operating for approximately 177 years, making it the more established of the two companies. Amphenol Corporation has been in operation for around 94 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Amphenol vs Pfizer overview